Health

ExamWorks Announces Strategic Leadership Transition Plan to Further Accelerate Long-Term Growth

ATLANTA, GA, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ExamWorks Group (“ExamWorks”), a leading global provider of medical claims management solutions,…

12 hours ago

RadNet Names Four Leaders to Expanded Executive Roles

LOS ANGELES, Jan. 07, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient…

12 hours ago

LIfT BioSciences Announces CEO Transition to Drive Next Phase of Growth with Neutrophil-based Therapies

Dr. Bo Rode Hansen, current Board member and Corporate Development Officer named Interim CEO Alex Blyth, Founder and CEO to step…

12 hours ago

Day One Completes Acquisition of Mersana Therapeutics

Acquisition expands Day One’s pipeline with clinical-stage antibody drug conjugate (ADC) emiltatug ledadotin (Emi-Le) targeting rare cancer adenoid cystic carcinoma…

1 day ago

Medical AI Expert Wido Menhardt Joins FemPulse Scientific Advisory Board

January 06, 2026 09:00 ET  | Source: FemPulse SAN FRANCISCO, Jan. 06, 2026 (GLOBE NEWSWIRE) -- FemPulseTM, a bioelectronic medical…

1 day ago

Visory Health Named to Inc.s Best in Business for Excellence in Social Good

ESTERO, Fla., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Visory Health, a patient-first health tech prescription platform that is transforming the…

1 day ago

Plum Tree Launches 2026 with Expanded Access to Mental Health Care for Children and Adolescents

ST. CHARLES, Ill., Jan. 05, 2026 (GLOBE NEWSWIRE) -- As families enter the new year, Plum Tree Psychology, a child…

2 days ago

Idorsias daridorexant in women during menopausal transition age with insomnia

New analysis of a Phase 3 study of daridorexant shows that 50 mg improved both sleep and daytime functioning compared…

2 days ago

Zealand Pharma to present at the J.P. Morgan Healthcare Conference

January 05, 2026 11:05 ET  | Source: Zealand Pharma Press release – No. 1 / 2026 Zealand Pharma to present…

2 days ago

Crinetics Pharmaceuticals to Provide PALSONIFY Business Update and Announce Topline Results from Fourth Cohort of Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia

January 04, 2026 16:00 ET  | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO, Jan. 04, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals,…

3 days ago